EUVIMEDEUVIMED entdecken
Multizentrische Studie

Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy

Rachel Woodford, Janet McKeown, Lotte L Hoeijmakers, Johanna Mangana, Florentia Dimitriou, Clara Allayous, Farzana Zaman, Francisco Aya, John Marsiglio, Rachel Goodman, Victoria Rayson, Joanna Placzke und 25 weitere

European Journal of Cancer · 2024

DOI: 10.1016/j.ejca.2024.115055 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Rachel Woodford und 36 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma Institute Australia, University of Sydney, 45 Rocklands Road, Wollstonecraft, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Melanoma, Neoplasm Recurrence, Local, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Melanoma Institute Australia, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaNeoplasm Recurrence, LocalImmune Checkpoint InhibitorsHumansMaleFemaleMiddle AgedAgedAdultRetrospective StudiesAged, 80 and overYoung AdultAdolescentChemotherapy, AdjuvantSkin NeoplasmsProgrammed Cell Death 1 Receptor

Stichwörter der Autor:innen

AdjuvantAnti-PD-1 therapyDistant recurrenceImmunotherapyImmunotherapy resistanceLocoregional recurrenceMelanomaRecurrent disease

Substanzen

Immune Checkpoint InhibitorsProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Melanoma Institute Australia, University of Sydney, 45 Rocklands Road, Wollstonecraft, Sydney, NSW, Australia.
  • Department of Medical Oncology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, Amsterdam, The Netherlands.
  • Department of Dermatology, University Hospital of Zurich, University of Zurich, Ramistrasse 100, Zurich, Switzerland.
  • APHP Hospital St-Louis, Dermatology Department, DMU ICARE, Paris, France.
  • Department of Medical Oncology, The Alfred Hospital, 55 Commercial Road, Melbourne, Victoria, Australia.
  • Hospital Clinic Barcelona, Calle de Villaroel 170, Barcelona, Spain.

Förderung

  • Melanoma Institute Australia
  • National Health and Medical Research Council

Zitieren

APA

Woodford, R., McKeown, J., Hoeijmakers, L. L., Mangana, J., Dimitriou, F., Allayous, C., Zaman, F., Aya, F., Marsiglio, J., Goodman, R., Rayson, V., Placzke, J., Kessels, J., Ramalyte, E., Haque, W., Wilson, I., Trojaniello, C., Benannoune, N., Roberts-Thomson, R., …, & Menzies, A. M. (2024). Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.115055

Vancouver

Woodford R, McKeown J, Hoeijmakers LL, Mangana J, Dimitriou F, Allayous C, et al. Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.115055

BibTeX
@article{Woodford2024,
  author = {Woodford, Rachel and McKeown, Janet and Hoeijmakers, Lotte L and Mangana, Johanna and Dimitriou, Florentia and Allayous, Clara and Zaman, Farzana and Aya, Francisco and Marsiglio, John and Goodman, Rachel and Rayson, Victoria and Placzke, Joanna and Kessels, Jolien and Ramalyte, Egle and Haque, Waqas and Wilson, Isabella and Trojaniello, Claudia and Benannoune, Naima and Roberts-Thomson, Rachel and Robert, Caroline and Blank, Christian U and Dummer, Reinhard and Lebbe, Celeste and Haydon, Andrew and Arance, Ana and Hu-Lieskovan, Siwen and Johnson, Douglas B and Mcarthur, Grant A and Rutkowski, Piotr and Neyns, Bart and Sullivan, Ryan J and Weber, Jeffrey and Carlino, Matteo S and Ascierto, Paolo A and Lo, Serigne and Long, Georgina V and Menzies, Alexander M},
  title = {Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy},
  journal = {European Journal of Cancer},
  year = {2024},
  doi = {10.1016/j.ejca.2024.115055}
}
Kostenlos starten →